NEW YORK (Reuters Health) – For frail older adults with atrial fibrillation (AF), apixaban has benefits over other direct oral anticoagulants (DOACs) and warfarin, a new analysis suggests. Examining outcomes with different DOACs (versus warfarin) by frailty levels, researchers founds…
Read MorePulsed Field Ablation Effective Against Paroxysmal Atrial Fibrillation
NEW YORK (Reuters Health) – Pulsed field ablation (PFA), a new nonthermal ablation approach that preferentially ablates myocardial tissue, results in durable pulmonary vein isolation (PVI) and a low rate of recurrence of atrial arrhythmia, according to one-year outcomes of…
Read More